2086
J. C. González-Gómez et al.
SPECIAL TOPIC
(RS)-N-{(1R)-1-[(1R,2S,6R)-2-Ethyl-6-hydroxycyclohexyl]-3-
phenylpropyl}-2-methylpropane-2-sulfinamide (4a); Typical
Procedure for Reduction with NaBH4
1H NMR (300 MHz, CD3OD): d = 7.26 (m, 2 H), 7.15 (m, 3 H), 4.23
(m, 1 H), 3.45 (m, 1 H), 2.75 (dt, J = 13.3, 5.9 Hz, 1 H), 2.56 (dt,
J = 13.3, 8.2 Hz, 1 H), 1.85–1.65 (m, 6 H), 1.50 (m, 1 H), 1.40 (m,
2 H), 1.20 (s, 9 H), 1.15–0.80 (m, 3 H), 0.74 (t, J = 7.3 Hz, 3 H).
13C NMR (75 MHz, CD3OD): d = 9.9 (CH3), 20.5 (CH2), 23.6
(CH3), 25.9 (CH2), 31.6 (CH2), 33.4 (CH), 33.9 (CH2), 35.6 (CH2),
39.7 (CH2), 47.9 (CH), 57.45 (q), 57.50 (CH), 67.8 (CH), 126.9
(CH), 129.5 (CH), 129.9 (CH), 143.2 (q).
NaBH4 (100 mg, 2.6 mmol) was added to a soln of 3a (492 mg, 1.36
mmol) in 95% EtOH (7 mL) at 0 °C, and the mixture was stirred at
0 °C for 2 h (TLC monitoring; hexane–EtOAc, 1:1). Sat. aq NH4Cl
was then carefully added (5 mL). When gas evolution ceased, the
mixture was partitioned between EtOAc (50 mL) and H2O (20 mL).
The aqueous phase was extracted with more EtOAc (2 × 20 mL),
and the combined organics extracts were washed with brine (10
mL) and dried (MgSO4). The filtered soln was concentrated in
vacuo to give pure 4a as a colorless solid; yield: 471 mg (96%); mp
175–178 °C; [a]D20 –5.2 (c 1.00, EtOH).
MS (EI, 70 eV): m/z (%) = 91.0 (72), 117.0 (100), 181.0 (42), 227
(20), 309 (21) [M – C4H8]+.
Compound 4d: [a]D20 –96.7 (c 0.65, EtOH).
IR (KBr): 3374, 3222, 2928, 1455, 1362, 1033 cm–1.
IR (KBr): 3374, 3222, 2928, 1455, 1362, 1033 cm–1.
1H NMR (300 MHz, CD3OD): d = 7.25 (m, 5 H), 3.56 (td, J = 10.3,
4.4 Hz, 1 H), 3.25 (m, 1 H), 2.89 (dt, J = 13.8, 6.0 Hz, 1 H), 2.78 (dt,
J = 13.8, 8.4 Hz, 1 H), 1.80 (m, 3 H), 1.60 (m, 1 H), 1.50 (m, 1 H),
1.25 (m, 4 H), 1.20 (s, 9 H), 1.15–0.80 (m, 4 H), 0.60 (t, J = 7.2 Hz,
3 H).
13C NMR (75 MHz, CD3OD): d = 9.7 (CH3), 23.2 (CH3), 25.0
(CH2), 25.7 (CH2), 31.8 (CH2), 33.3 (CH2), 34.6 (CH2), 37.6 (CH2),
39.7 (CH), 54.1 (CH), 57.2 (q), 58.4 (CH), 73.1 (CH), 126.9 (CH),
129.4 (CH), 130.1 (CH), 143.4 (q).
1H NMR (400 MHz, CD3OD): d = 7.26 (m, 2 H), 7.15 (m, 3 H), 3.56
(td, J = 10.1/3.9 Hz, 1 H), 3.36 (m, 1 H), 2.83 (dt, J = 13.3, 5.9 Hz,
1 H), 2.55 (dt, J = 13.3, 8.2 Hz, 1 H), 1.75 (m, 3 H), 1.65–1.45 (m,
3 H), 1.27 (m, 2 H), 1.24 (s, 9 H), 1.15–0.80 (m, 4 H), 0.67 (t, J = 7.2
Hz, 3 H).
13C NMR (100 MHz, CD3OD): d = 9.9 (CH3), 23.5 (CH3), 25.1
(CH2), 25.6 (CH2), 30.7 (CH2), 31.9 (CH2), 33.5 (CH2), 37.5 (CH2),
40.0 (CH), 53.7 (CH), 57.3 (q), 58.3 (CH), 73.6 (CH), 127.0 (CH),
129.5 (CH), 129.9 (CH), 143.2 (q).
MS (EI, 70 eV): m/z (%) = 91.0 (68), 117.0 (100), 181.0 (44), 227
(7), 309 (54) [M – C4H8]+.
MS (EI, 70 eV): m/z (%) = 91.0 (68), 117.0 (100), 181.0 (44), 227
(7), 309 (54) [M – C4H8]+.
HRMS–EI: m/z [M – C4H8]+ calcd for C17H27NO2S: 309.1762;
found: 309.1781.
(SS)-N-{(1R)-1-[(1R,2R,6S)-2-Ethyl-6-hydroxycyclohexyl]-3-
phenylpropyl}-2-methylpropane-2-sulfinamide (ent-4c) and
(SS)-N-{(1S)-1-[(1R,2R,6S)-2-Ethyl-6-hydroxycyclohexyl]-3-
phenylpropyl}-2-methylpropane-2-sulfinamide (ent-4d)
By following the typical procedure, a 2.4:1 mixture of ent-3b and
ent-3c (500 mg) was reduced with NaBH4 (120 mg). After FC (hex-
ane–EtOAc, 3:2 to 1:1), pure ent-4c and ent-4d were obtained as
colorless foams; ent-4c; yield: 201 mg (40%); [a]D20 +74.0 (c 0.85,
MeOH), ent-4d; yield: 103 mg (20%); [a]D20 +95.0 (c 0.65, MeOH).
Crystal Structure:13 C21H35NO2S, M = 365.57; triclinic,
a = 9.5123(11) Å, b = 9.7013(11) Å, c = 13.3331(15) Å,
a = 94.474(2), b = 110.126(2), g = 105.743(2); V = 1091.8(2) Å3;
space group P1; Z = 2; Dc = 1.112 Mg m–3; l = 0.71073 Å;
m = 0.161 mm–1; F(000) = 400; T = 23 1 °C. Data collection was
performed on a Bruker Smart CCD diffractometer, based on three
w-scan runs (starting = –34°) at values f = 0°, 120°, and 240° with
the detector at 2q = –32°. For each of these runs, 606 frames were
collected at 0.3° intervals and 20 s per frame. An additional run at
f = 0° of 100 frames was collected to improve redundancy. The
diffraction frames were integrated by using the program SAINT,14a
and the integrated intensities were corrected for Lorentz polariza-
tion effects with SADABS.14b The structure was solved by direct
(RS)-N-{(1R)-1-[(1S,2S,6S)-2-Ethyl-6-hydroxycyclohexyl]-3-
phenylpropyl}-2-methylpropane-2-sulfinamide (4b); Typical
Procedure for Reduction with LiBHEt3
A 1 M soln of LiBHEt3 in THF (9 mL, 9 mmol) was added dropwise
from a syringe to a soln of 3a (530 mg, 1.50 mmol) in anhyd THF
(24 mL) at –78 °C under argon, and the mixture was stirred for 3 h
at –78 °C (TLC monitoring; hexane–EtOAc, 1:2). 1:1 MeOH–aq
NH4Cl (10 mL) was added and the mixture was stirred for an addi-
tional 15 min while the temperature increased to r.t. and gas evolu-
tion ceased. The mixture was partitioned between EtOAc (50 mL)
and H2O (20 mL), and the aqueous phase was extracted with addi-
tional EtOAc (2 × 20 mL). The combined organics extracts were
washed with brine (10 mL) and dried (MgSO4). The filtered soln
was concentrated in vacuo to give crude 4b, which was triturated
with hexane (10 mL) to give a precipitate that was filtered off to
give pure 4b as a colorless solid; yield: 445 mg (82%); mp 152–155
°C; [a]D20 +51.0 (c 0.60, EtOH).
2
methods and refined to all 7190 unique Fo by full-matrix least-
squares.14c All the hydrogen atoms were placed at idealized posi-
tions and refined as rigid atoms. Final wR2 = 0.1448 for all data and
467 parameters; R1 = 0.0613 for 4885 Fo > 4s(Fo).
(SS)-N-{(1R)-1-[(1R,2S,6R)-2-Ethyl-6-hydroxycyclohexyl]-3-
phenylpropyl}-2-methylpropane-2-sulfinamide (ent-4a)
By following the typical procedure starting from ent-3a (616 mg,
1.70 mmol) and NaBH4 (120 mg), pure compound ent-4a was ob-
tained as a colorless solid; yield: 565 mg (92%); [a]D20 +5.0 (c 1.00,
EtOH).
IR (KBr): 3208 (br), 2956, 1456, 1355, 1025 cm–1.
(RS)-N-{(1R)-1-[(1R,2R,6S)-2-Ethyl-6-hydroxycyclohexyl]-3-
phenylpropyl}-2-methylpropane-2-sulfinamide (4c) and (RS)-
N-{(1S)-1-[(1R,2R,6S)-2-Ethyl-6-hydroxycyclohexyl]-3-phenyl-
propyl}-2-methylpropane-2-sulfinamide (4d)
By following the typical procedure, a 2.4:1 mixture of 3b and 3c
(550 mg, 1.50 mmol) was reduced by NaBH4 (110 mg, 2.9 mmol).
After solvent evaporation, the residue was purified by FC (hexane–
EtOAc, 3:2 to 1:1) to give pure compounds 4c and 4d as colorless
foams; yield: 4c: 244 mg (44%); 4d: 116 mg (21%).
1H NMR (300 MHz, CD3OD): d = 7.26 (m, 2 H), 7.15 (m, 3 H), 4.20
(m, 1 H), 3.38 (m, 1 H), 2.75 (dt, J = 13.3, 5.9 Hz, 1 H), 2.53 (dt,
J = 13.3, 8.2 Hz, 1 H), 1.90 (m, 1 H), 1.80 (m, 1 H), 1.60 (m, 2 H),
1.50 (m, 2 H), 1.40 (m, 2 H), 1.23 (s, 9 H), 1.15 (m, 1 H), 0.80 (m,
3H), 0.64 (t, J = 7.3 Hz, 3 H).
13C NMR (75 MHz, CD3OD): d = 10.3 (CH3), 20.9 (CH2), 23.4
(CH3), 25.5 (CH2), 32.2 (CH2), 34.7 (CH2), 34.8 (CH2), 35.2 (CH),
51.2 (CH), 57.8 (q), 59.9 (CH), 67.2 (CH), 126.9 (CH), 129.4 (CH),
129.8 (CH), 143.3 (q).
Compound 4c: [a]D20 –76.5 (c 0.65, EtOH).
IR (KBr): 3374, 3222, 2928, 1455, 1362, 1033 cm–1.
MS (EI, 70 eV): m/z (%) = 91.0 (72), 117.0 (100), 181.0 (42), 227
(20), 309 (21) [M – C4H8]+.
Synthesis 2009, No. 12, 2083–2088 © Thieme Stuttgart · New York